000 01491 a2200421 4500
005 20250516114541.0
264 0 _c20130115
008 201301s 0 0 eng d
022 _a1550-6606
024 7 _a10.4049/jimmunol.1103551
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGresnigt, Mark S
245 0 0 _aNeutrophil-mediated inhibition of proinflammatory cytokine responses.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cNov 2012
300 _a4806-15 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCandida albicans
_ximmunology
650 0 4 _aCandidiasis
_ximmunology
650 0 4 _aCytokines
_ximmunology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInflammation Mediators
_ximmunology
650 0 4 _aLipopolysaccharides
_xpharmacology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNeutrophils
_ximmunology
650 0 4 _aPhagocytosis
_xdrug effects
650 0 4 _aReactive Oxygen Species
_ximmunology
700 1 _aJoosten, Leo A B
700 1 _aVerschueren, Ineke
700 1 _avan der Meer, Jos W M
700 1 _aNetea, Mihai G
700 1 _aDinarello, Charles A
700 1 _avan de Veerdonk, Frank L
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 189
_gno. 10
_gp. 4806-15
856 4 0 _uhttps://doi.org/10.4049/jimmunol.1103551
_zAvailable from publisher's website
999 _c22173512
_d22173512